Monday, December 17, 2018
Vitafood – Home events – may 2019

Latest news

Axovant in-licences gene therapies from UMass

Axovant in-licences gene therapies from UMass

Axovant Sciences has licensed exclusive worldwide rights for the development and commercialisation of two novel gene therapy programs to address GM1 gangliosidosis and GM2...
European approval for self-administration of Novartis’ Xolair

European approval for self-administration of Novartis’ Xolair

Novartis has this week secured approval in Europe for Xolair prefilled syringe for self-administration. The treatment allows patients with severe allergic asthma (SAA) and chronic...
Bausch Health acquiring beleaguered Synergy out of bankruptcy

Bausch Health acquiring beleaguered Synergy out of bankruptcy

Bausch Health Companies has acquired biopharma Synergy Pharmaceuticals out of bankruptcy for $200 million. News of the acquisition comes as the beleaguered company filed a...